Page 38 - Human Longevity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Plenty of private longevity research companies are working on innovative studies aimed at diseases associated with the aging process, including cardiovascular disease, type 2 diabetes and various cancers. If they do go public one day, investors who have them on their radar already will be ahead of the game. Here’s a short list of some of the top private longevity research companies making headlines today. 1. Sanumed Sanumed is first on our list of longevity research companies. Based in San Diego, California, the company develops small-molecule, tissue-level therapeutic drugs aimed at treati...

Youth Using E-cigarettes Three Times as Likely to Become Daily Cigarette Smokers, Says Study by Colleen Fleiss on  January 11, 2021 at 11:44 PM The use of tobacco products before 18 years is a key risk factor for people to become daily cigarette smokers, revealed an analysis of a large nationally representative longitudinal study by University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science. Reporting in the January 11, 2021 online edition of Pediatrics, researchers found that in 2014 people age 12 to 24 who used e-cigarettes w...

Youth using e-cigarettes three times as likely to become daily cigarette smokers: Study ANI | Updated: Jan 11, 2021 11:24 IST California [US], January 11 (ANI): Starting tobacco products, including e-cigarettes, before the age of 18 is a major risk factor for people becoming daily cigarette smokers, suggests a new study. This was reported in the analysis of a large nationally representative longitudinal study by the University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science. Reporting in the online edition of P...

Starting tobacco products, including e-cigarettes, before the age of 18 is a major risk factor for people becoming daily cigarette smokers, suggests a new study

Cancer and genetic testing drove diagnostics industry M&A boom in 2020 Kelsy Ketchum, 360Dx Print Despite the coronavirus pandemic making waves in economies around the world, the diagnostics market benefitted from increased investor interest and an upswing in mergers and acquisitions in 2020. Overall, the numbers of mergers and acquisitions in the diagnostics industry increased 38% to 54% in 2020 from 39 in 2019. Included in the analysis are deals in the molecular and non-molecular in vitro diagnostic spaces that were announced or completed this past year. In most cases, only acquisitions of...